The global metabolomics technology market is estimated to register robust growth in 2016- 2022 and is expected to grow at CAGR of 30.5% during 2016-2022. The metabolomics technology market is segmented on the basis of application, technique, indication and geography. The application segment is segmented into discovery & drug assessment, toxicology testing, biomarker discovery, nutrigenomics, and others. The technique segment is segmented into detection techniques and separation techniques. The indication segment is also segmented into cardiology, oncology, neurology and others. In indication segment cardiology accounts to large market share, the dominance is majorly driven by the increasing prevalence of cardiovascular diseases across the globe. Whereas the oncology segment is expected to grow with the high CAGR during the forecasted period 2016-2022.

The growing demand for personalized medicines and rising growth in the biotechnology and pharmaceutical industry is increasing the growth in the global metabolomics technology market. Various key players and other government organization are indulging in various research and development activity for development of personalized medicines to enhance efficiency which assist in capturing the market potential available in the emerging economies. Various key players are adopting strategic moves to maintain position in the global metabolomics technology market. The huge demand for the toxicity technology is the major factor that is pushing the scope for metabolomics technology in the global market.

The increase in the chronic diseases and growing aging population across the world is increased demand for the personalized medicines across the globe. The growing demand for personalized medicine is one of the major factors that is increasing the scope of metabolomics technology in global market. However, the low adoption rate across various geographies is hampering the growth in the global market. The global metabolomics technology market is having huge opportunities such as growing demand for the metabolomics technology from the emerging countries which is creating huge growth opportunities in the forecasted period. The availability of enormous potential in emerging countries is the major factor which is also injecting huge growth opportunity in the global market and increasing the scope of global Metabolomics Technology market.

On the basis of geography North America, Europe, Asia Pacific and ROW are the major segments. The North America holds the largest market share followed by Europe, Asia Pacific and ROW in the global Metabolomics Technology market. The growth in North America market is majorly driven by the growing demand for toxicity technology in the North American region. Whereas the growing research and development expenditure for the development of new metabolomics technology in the region by the key players and various health and research organization is also boosting the growth in the North America market. The Europe metabolomics technology market is expected to grow with the fastest growing CAGR during the forecasted period. Whereas Asia pacific Metabolomics Technology market is expected to grow with an impressive CAGR during the forecasted period 2016-2022. The growth in the region is majorly driven by the huge demand for the personalized medicines in countries such as China and India as these countries have large patient pool in the world.